Thierry Muanza

ORCID: 0000-0001-9281-1668
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Glioma Diagnosis and Treatment
  • Breast Cancer Treatment Studies
  • Brain Metastases and Treatment
  • Lung Cancer Treatments and Mutations
  • Radiomics and Machine Learning in Medical Imaging
  • Advanced Radiotherapy Techniques
  • Cancer Treatment and Pharmacology
  • Breast Lesions and Carcinomas
  • DNA Repair Mechanisms
  • Angiogenesis and VEGF in Cancer
  • Nonmelanoma Skin Cancer Studies
  • Cancer survivorship and care
  • Prostate Cancer Treatment and Research
  • Effects of Radiation Exposure
  • HER2/EGFR in Cancer Research
  • Cancer, Hypoxia, and Metabolism
  • Oral health in cancer treatment
  • Chemotherapy-related skin toxicity
  • PARP inhibition in cancer therapy
  • Meningioma and schwannoma management
  • Head and Neck Cancer Studies
  • Colorectal Cancer Treatments and Studies
  • Lung Cancer Diagnosis and Treatment
  • Cancer therapeutics and mechanisms
  • Cancer Diagnosis and Treatment

McGill University
2013-2024

Jewish General Hospital
2015-2024

McGill University Health Centre
2003-2023

Montreal Neurological Institute and Hospital
2013-2022

University of Manitoba
2019

Western University
2019

University of Calgary
2019

McMaster University
2019

Okanagan University College
2019

University of British Columbia
2019

10.1016/s0140-6736(19)32515-2 article EN The Lancet 2019-12-01

Abstract In this study, we sought to explore the merit of proteomic profiling strategies in patients with cancer before and during radiotherapy an effort discover clinical biomarkers radiation exposure. Patients a diagnosis provided informed consent for enrollment on study permitting collection serum immediately course therapy. High-resolution surface-enhanced laser desorption ionization-time flight (SELDI-TOF) mass spectrometry (MS) was used generate high-throughput profiles unfractionated...

10.1158/0008-5472.can-05-3466 article EN Cancer Research 2006-02-01

Background and Purpose: No longer considered a single disease entity, breast cancer is being classified into several distinct molecular subtypes based on gene expression profiling. These appear to carry prognostic implications have the potential be incorporated treatment decisions. In this study, we evaluated patterns of local recurrence (LR), distant metastasis (DM), association survival with subtype in patients post–adjuvant radiotherapy setting. Material Methods: The medical records 1,088...

10.7759/cureus.924 article EN Cureus 2016-12-09

2008 Background: For non-small cell lung cancer (NSCLC) with brain metastases (BM) stereotactic radiosurgery (SRS) is the current preferred therapy. Due to frequent intracranial failures, there a high unmet need for salvage therapies. Whole radiotherapy (WBRT) reduces failure but used less frequently due cognitive consequences. Tumor Treating Fields (TTFields) are electric fields that disrupt division and have shown improved survival safety in patients glioblastoma metastatic NSCLC. Phase 3...

10.1200/jco.2024.42.16_suppl.2008 article EN Journal of Clinical Oncology 2024-06-01

Perinatal hypoxic/ischemic (HI) brain injury is a major clinical problem with devastating neurodevelopmental outcomes in neonates. During HI injury, dysregulated factor production contributes to microvascular impairment. Glycolysis-derived lactate accumulated during ischemia has been proposed protect against ischemic but its mechanism of action poorly understood. Herein, we hypothesize that via G-protein coupled receptor (GPR81) controls postnatal angiogenesis and plays protective role after...

10.1177/0271678x221077499 article EN Journal of Cerebral Blood Flow & Metabolism 2022-02-02

Purpose To determine the predictive value of urinary levels two angiogenic factors, vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMPs), in a longitudinal study to their correlation with 1-year progression-free survival patients cancer. Patients Methods VEGF MMP were measured urine 65 cancer at first evaluation, during therapy, follow-up (n = 242); normalized by creatinine levels; compared 16 healthy controls. The initial trends MMPs was assessed using two-sample...

10.1200/jco.2004.07.022 article EN Journal of Clinical Oncology 2004-01-30

Abstract Experiments described herein were designed to evaluate the performance characteristics of a flow cytometry‐based system that scores incidence peripheral blood micronucleated reticulocytes (MN‐RETs). These procedures represent continued refinement previously reported anti‐CD71‐based method (Dertinger et al. [1996]: Mutat Res 371:283–292), with following modifications: incorporation third fluorescent label exclude platelets from MN‐RET region, and use CD71‐associated fluorescence...

10.1002/em.20075 article EN Environmental and Molecular Mutagenesis 2004-01-01

Abstract Purpose: Optical coherence tomography (OCT) imaging was evaluated to determine if radiation-induced mucosal damage could be noninvasively monitored in real time and correlated with histopathologic findings. Experimental Design: Female C3H mice, ages 7 9 weeks, four per group, were immobilized a custom-made Lucite jig received 0, 15, 22.5, 25 Gy single fraction their oral cavity. OCT images acquired of proximal, middle, distal aspects the dorsum tongue on days 1, 3, 5,...

10.1158/1078-0432.ccr-05-0403 article EN Clinical Cancer Research 2005-07-15

Background Prostate cancer (PCa) is a progressive disease and the most diagnosed in men. The current standard of care for high‐risk localized PCa combination androgen deprivation therapy (ADT) radiation (XRT). majority these patients however become resistant due to incomplete responses ADT as result selective cells maintaining receptor (AR) activity. Improvement can be made if increasing radiosensitivity realized. Therefore, aim this study investigate efficacy next‐generation drug...

10.1002/pros.23445 article EN The Prostate 2017-11-14

Background Recent developments in artificial intelligence suggest that radiomics may represent a promising non-invasive biomarker to predict response immune checkpoint inhibitors (ICIs). Nevertheless, validation of algorithms independent cohorts remains challenge due variations image acquisition and reconstruction. Using radiomics, we investigated the importance scan normalization as part broader machine learning framework enable model external generalizability ICI non-small cell lung cancer...

10.3389/fonc.2023.1196414 article EN cc-by Frontiers in Oncology 2023-07-20

Adult medulloblastoma is a rare disease for which there no internationally accepted standard of care. Treatment regimens have typically been modeled after pediatric protocols. We sought to review the presentation, management, and outcome patients with adult treated at McGill University teaching hospitals over past 18 years.Medical records were reviewed gather demographic clinical data including presenting symptoms, tumor characteristics, survival, treatment toxicity.Twenty-five identified....

10.1002/pbc.21588 article EN Pediatric Blood & Cancer 2008-07-22

10.1016/j.ijrobp.2007.12.015 article EN International Journal of Radiation Oncology*Biology*Physics 2008-02-06

The authors reviewed their institutional experience with pure low-grade oligodendroglioma (LGO), correlating outcomes several variables of possible prognostic values.Sixty-nine patients WHO-classified LGOs were treated between 1992 and 2006 at the McGill University Health Center. Clinical, pathological, radiological records carefully reviewed. Demographic characteristics; nature duration presenting symptoms; baseline neurological function; extent resection; Karnofsky Performance Scale score;...

10.3171/2008.11.jns08983 article EN Journal of neurosurgery 2009-03-13

Radiation-induced dermatitis is a common side effect of breast irradiation, with hypofractionation being well-known risk factor. In the context widespread adoption hypofractionated radiotherapy, we evaluated radiotherapy on incidence skin toxicity in patients receiving adjuvant chemotherapy.We retrospectively reviewed records cancer treated from 2004 to 2006 at single institution. Patients undergoing lumpectomy or without chemotherapy followed by consisting 42.4 Gy 16 fractions were included...

10.3747/co.v17i5.604 article EN cc-by Current Oncology 2010-09-28

This pilot prospective study sought to determine whether dynamic contrast enhanced MRI (DCE-MRI) could be used as a clinical imaging biomarker of tissue toxicity from whole brain radiotherapy (WBRT).14 patients who received WBRT were imaged using DCE-MRI prior and at 8-weeks, 16-weeks 24-weeks after the initiation WBRT. Twelve also enrolled in RTOG 0614 trial, which randomized use placebo or memantine. After unblinding treatments by patients, measures tumor normal appearing white matter...

10.18632/oncotarget.9653 article EN Oncotarget 2016-05-28
Coming Soon ...